RSNA: Pulsed Radiofrequency Alleviates Low Back Pain

Share this content:
RSNA: Pulsed Radiofrequency Alleviates Low Back Pain
RSNA: Pulsed Radiofrequency Alleviates Low Back Pain

WEDNESDAY, Nov. 29, 2017 (HealthDay News) -- Computed tomography (CT)-guided pulsed radiofrequency is beneficial for patients with acute or subacute neuroradicular pain from lumbar disc herniation, according to a study presented at the annual meeting of the Radiological Society of North America, held from Nov. 26 to Dec. 1 in Chicago.

Alessandro Napoli, M.D., Ph.D., from Sapienza University in Rome, and colleagues treated 80 patients with acute or subacute neuroradicular low back pain, refractory to usual treatments. Patients were treated with a 22-20 G needle-electrode with probe tip directed to the symptomatic dorsal root ganglion under computed tomography guidance. E-pulsed radiofrequency was administered for 10 minutes at 45 V.

The researchers found that there were reductions from 7.8 at baseline to 3.5, 2.6, and 1.3, respectively, at one week, one month, and three months after treatment in the median Visual Analogue Scale (VAS) scores; from 78.0 to 12.5, 6.0, and 5.5, respectively, in the median Oswestry Disability Index (ODI) score; and from 16 at baseline to 3.0 and 1.5, respectively, at one and three months in the Roland-Morris score for quality of life assessment (P < 0.001). Within the first month after treatment, 90.0 percent of patients reached a 0 VAS score, and 97.5 percent had a decrease of at least 20 points in ODI score.

"The results have been extraordinary," Napoli said in a statement. "Patients have been relieved of pain and resumed their normal activities within a day."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »